As the title says, two fresh brand names out of the Orthocell stable.
"Orthocell are evaluating their platform of medical device products in a range of clinical uses, on its own or in combination with cell therapies. Striate+™ is cleared for supply in the US for guided bone and tissue regeneration in dental procedures. Our pipeline products are being evaluated for use in nerve (Remplir™and tendon (SMRT GRAFT™
*Remplir™ and SMRT GRAFT™ are not approved for supply in the US"
Remplir™ and SMRT GRAFT™
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23269 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |